Path Investments plc Further re the Acquisition of 75% of DT Ultravert (3105E)
05 11월 2020 - 4:00PM
UK Regulatory
TIDMPATH
RNS Number : 3105E
Path Investments plc
05 November 2020
Path Investments plc
("Path" or the "Company")
Extension of and Amendment to Agreement for the Acquisition of
75% of DT Ultravert from Zoetic International plc
Path Investments plc (TIDM: PATH) , the energy and natural
resources investment company, is pleased to announce the extension
of, and certain amendments to, its binding agreement with Zoetic
International plc ("Zoetic") for the acquisition of its 75%
ownership of DT Ultravert ("DTU").
As announced on 1 October 2020, Path has secured agreement for
the purchase of 25% of DTU from Diversion Technologies LLC
("Diversion") and therefore the conclusion of the acquisition from
Zoetic will unify DTU in one party's ownership for the first time.
Path considers this will be a key factor in the successful
marketing of DTU going forward.
The Company has previously announced that it is proceeding with
preparation for publication of a prospectus relating to its
acquisition of 100% of DTU from both Zoetic and Diversion and
readmission of Path's ordinary shares to the standard segment of
the Official List maintained by the Financial Conduct Authority and
to trading on the Main Market of the London Stock Exchange
("Re-admission"). This is progressing, but to accommodate the time
required to complete the matters associated with the Re-admission,
the Company and Zoetic have agreed to extend the long stop date
within the agreement. No such extension is required at this time
for the agreement with Diversion.
In addition, Path and Zoetic have taken the opportunity to amend
the consideration and structure of the transaction to match that
agreed with Diversion pro-rata.
Firstly, in order to simplify the transaction, the Kansas assets
will now be retained by Zoetic and accordingly they no longer form
part of the transaction. The Company has today agreed with GasRock
Limited that the conditional agreement announced by the Company on
5 October 2020 for their purchase of the Kansas assets is cancelled
with immediate effect, at no cost to either party.
Secondly, the consideration for the acquisition of the 75% of
DTU from Zoetic has been adjusted and will now be satisfied by the
issue by Path to Zoetic of 30,000,000 ordinary shares in Path on
Re-admission, together with the issue of 15,000,000 warrants to
subscribe for ordinary shares in Path at any time from the first to
the third anniversaries following completion of the acquisition at
an exercise price of 1.5 pence per ordinary share. In return,
Zoetic has agreed that no royalty payments will be made in respect
of revenue earned by Path from DTU.
Completion of the transactions with Zoetic and Diversion are
subject to a number of items, including the publication of a
prospectus by Path prepared in accordance with the Prospectus
Regulation Rules made under section 73A of the Financial Services
and Markets Act 2000 (as amended) and approved by the UK Financial
Conduct Authority under section 87A of Financial Services and
Markets Act 2000 (as amended) and Re-admission.
Commenting, Christopher Theis CEO of Path, said: "We are pleased
to have agreed the extension and amendment of our transaction with
Zoetic. We now have a more balanced and simplified transaction
structure which meets the needs of all parties and we look forward
to completion of the transaction shortly. The removal of the
ongoing royalty in return for the restructured consideration and
retention of the Kansas assets by Zoetic creates a cleaner
structure and one which is potentially more valuable to Path over
the long term."
The information contained within this announcement is deemed to
constitute inside information as stipulated under the Market Abuse
Regulations (EU) No. 596/2014. The public disclosure of this inside
information was delayed pursuant to Article 17(4) MAR.
For further information please contact:
Path Investments plc C /O IFC
Christopher Theis
IFC Advisory Limited (Financial PR & IR) 020 3934 6630
Tim Metcalfe
Zach Cohen
Grant Thornton UK LLP (Financial Adviser)
Jamie Barklem 020 7865 2692
Harrison Clarke 020 7184 4384
Keith, Bayley, Rogers & Co. Limited (Broker)
07776 30 22
Brinsley Holman 28
07506 43 41
Graham Atthill-Beck 07
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FURBIBMTMTJMTMM
(END) Dow Jones Newswires
November 05, 2020 02:00 ET (07:00 GMT)
Path Investments (LSE:PATH)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Path Investments (LSE:PATH)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025